According to the Motley Fool's Dan Caplinger's article dated 14/dec/2012 "Has Geron Become the Perfect Stock?" there could be a new buyer in the market for Geron's stem cell technology !
" [Geron] is still trying to find a buyer for its stem-cell unit. Geron has a non-binding deal with BioTime (NYSEMKT: BTX ) for the division, but with speculation that Teva Pharmaceutical (NYSE: TEVA ) or another big pharma stock could make a competing bid ,Geron is hoping to get some cash to further its own research." writes Caplinger,
Could we be seeing a stem cell hub in the making ?
Teva's silence re its stem cell aspirations are deafening !!
dyor
According to the Motley Fool's Dan Caplinger's article dated...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.045(2.98%) |
Mkt cap ! $1.672B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.50 | $1.45 | $8.307M | 5.669M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 151320 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 55652 | 2 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |